Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PEXEVA

PAROXETINE MESYLATE

Standard Dose
EQ 30MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PEXEVA is listed in Drugs@FDA under application 021299 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PAROXETINE MESYLATE Form and strength TABLET;ORAL - EQ 30MG BASE Sponsor SEBELA IRELAND LTD Submission history Latest submission status date: 2023-08-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview PEXEVA is listed in Drugs@FDA under application 021299 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PAROXETINE MESYLATE Form and strength TABLET;ORAL - EQ 30MG BASE Sponsor SEBELA IRELAND LTD Submission history Latest submission status date: 2023-08-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.